Figure 6.
Effects of WNT inhibition on GVL and survival in the A20 leukemia model. (A) In mice injected with 20 000 A20 cells, comparable survival times were noted in G007-LK–, pyrvinium-, salinomycin-, or vehicle-treated mice with syngeneic or allogeneic transplantation. Survival over time is shown as Kaplan-Meier curves. P < .005, allogeneic vs syngeneic. For WNT inhibitor treatment groups, no significant differences compared with vehicle-treated mice (n = 8 mice per group). (B) Percentage of yfp+ tumor cells in the peripheral blood of G007-LK–, pyrvinium-, salinomycin-, or sham-treated mice with syngeneic or allogeneic transplantation injected with A20 yfp/luc cells, as determined by flow cytometry on days 11, 16, and 25 post–A20 injection (n = 8 mice per group). *P < .5; **P < .05; ***P < .01. ns, not significant.

Effects of WNT inhibition on GVL and survival in the A20 leukemia model. (A) In mice injected with 20 000 A20 cells, comparable survival times were noted in G007-LK–, pyrvinium-, salinomycin-, or vehicle-treated mice with syngeneic or allogeneic transplantation. Survival over time is shown as Kaplan-Meier curves. P < .005, allogeneic vs syngeneic. For WNT inhibitor treatment groups, no significant differences compared with vehicle-treated mice (n = 8 mice per group). (B) Percentage of yfp+ tumor cells in the peripheral blood of G007-LK–, pyrvinium-, salinomycin-, or sham-treated mice with syngeneic or allogeneic transplantation injected with A20 yfp/luc cells, as determined by flow cytometry on days 11, 16, and 25 post–A20 injection (n = 8 mice per group). *P < .5; **P < .05; ***P < .01. ns, not significant.

Close Modal

or Create an Account

Close Modal
Close Modal